Last Posted: Oct 04, 2018
- Companies Tout Psychiatric Pharmacogenomic Testing, But Is It Ready for a Store Near You?
J Abbasi, JAMA, October 3, 2018 - Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults.
Chan Sze Ling et al. The pharmacogenomics journal 2018 Sep - Pharmacogenetic content of commercial genome-wide genotyping arrays.
Lemieux Perreault Louis-Philippe et al. Pharmacogenomics 2018 Oct - Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy: Progress Continues.
Diouf Barthelemy et al. Clinical pharmacology and therapeutics 2018 Sep - Use of combinatorial pharmacogenomic guidance in treating psychiatric disorders: financial impact on a health plan.
Benitez Joachim et al. Personalized medicine 2018 Sep - Naked-eye fingerprinting of single nucleotide polymorphisms on psoriasis patients.
Valentini Paola et al. Nanoscale 2016 Jun 8(21) 11027-33 - Pharmacogenomics of Alzheimer's and Parkinson's diseases.
Cacabelos Ramón et al. Neuroscience letters 2018 Sep - Pharmacogenomics/Updated for precision medicine in dermatology.
Do Le Hanh Dung et al. The Journal of dermatological treatment 2018 Sep 1-18 - An optimized prediction framework to assess the functional impact of pharmacogenetic variants.
Zhou Yitian et al. The pharmacogenomics journal 2018 Sep - Pharmacogenetic profile and major depressive and/or bipolar disorder treatment: a retrospective, cross-sectional study.
Tonozzi Theresa R et al. Pharmacogenomics 2018 Sep
No hay comentarios:
Publicar un comentario